136 related articles for article (PubMed ID: 1709355)
1. Prostate specific antigen. A review.
Brawer MK
Acta Oncol; 1991; 30(2):161-8. PubMed ID: 1709355
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen in management of prostatic carcinoma.
Brawer MK; Lange PH
Urology; 1989 May; 33(5 Suppl):11-6. PubMed ID: 2469244
[TBL] [Abstract][Full Text] [Related]
3. Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia.
Pretlow TG; Pretlow TP; Yang B; Kaetzel CS; Delmoro CM; Kamis SM; Bodner DR; Kursh E; Resnick MI; Bradley EL
Int J Cancer; 1991 Nov; 49(5):645-9. PubMed ID: 1718912
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
Mulders TM; Bruning PF; Bonfrer JM
Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen in prostatic cancer.
Baron JC; Peyret C; Leroy M; Teillac P; Najean Y; Le Duc A
Am J Clin Oncol; 1988; 11 Suppl 2():S75-6. PubMed ID: 2468279
[TBL] [Abstract][Full Text] [Related]
6. The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer.
Armitage TG; Cooper EH; Newling DW; Robinson MR; Appleyard I
Br J Urol; 1988 Dec; 62(6):584-9. PubMed ID: 2464397
[TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
[TBL] [Abstract][Full Text] [Related]
8. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.
Benson MC; Whang IS; Pantuck A; Ring K; Kaplan SA; Olsson CA; Cooner WH
J Urol; 1992 Mar; 147(3 Pt 2):815-6. PubMed ID: 1371554
[TBL] [Abstract][Full Text] [Related]
9. The effects of transurethral prostatectomy on serum prostate specific antigen.
Vesey SG; Goble NM; Stower MJ; Hammonds JC; Smith PJ
Br J Urol; 1988 Oct; 62(4):347-51. PubMed ID: 2461243
[TBL] [Abstract][Full Text] [Related]
10. Quantification of prostatic cancer metastatic disease using prostate-specific antigen.
Vesey SG; Goble M; Ferro MA; Stower MJ; Hammonds JC; Smith PJ
Urology; 1990 Jun; 35(6):483-6. PubMed ID: 1693796
[TBL] [Abstract][Full Text] [Related]
11. Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy.
Marrink J; Oosterom R; Bonfrer HM; Schröder FH; Mensink HJ
Eur J Cancer; 1993; 29A(4):570-1. PubMed ID: 7679580
[TBL] [Abstract][Full Text] [Related]
12. Medically significant concentrations of prostate-specific antigen in serum assessed.
Bernstein LH; Rudolph RA; Pinto MM; Viner N; Zuckerman H
Clin Chem; 1990 Mar; 36(3):515-8. PubMed ID: 1690092
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and discriminative ability of prostate-specific antigen as a tumor marker.
Leitenberger A; Altwein JE
Eur Urol; 1990; 17(1):12-6. PubMed ID: 1690653
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
15. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.
Oesterling JE
J Urol; 1991 May; 145(5):907-23. PubMed ID: 1707989
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase in prostatic disease.
Buamah PK; Johnson P; Skillen AW
Br J Urol; 1988 Dec; 62(6):581-3. PubMed ID: 2464396
[TBL] [Abstract][Full Text] [Related]
17. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
[TBL] [Abstract][Full Text] [Related]
18. Serum prostate-specific antigen discriminates weakly between men with benign prostatic hyperplasia and patients with organ-confined prostate cancer.
Sershon PD; Barry MJ; Oesterling JE
Eur Urol; 1994; 25(4):281-7. PubMed ID: 7519989
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen predominantly forms a complex with alpha 1-antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum.
Lilja H; Cockett AT; Abrahamsson PA
Cancer; 1992 Jul; 70(1 Suppl):230-4. PubMed ID: 1376193
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of prostate-specific antigen in untreated prostatic carcinoma.
Oosterom R; Bogdanowicz J; Schröder FH
Eur Urol; 1989; 16(4):253-7. PubMed ID: 2475344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
